The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center
Open accessAbstract
PURPOSE: To identify predictors of oncologic outcomes after percutaneous radiofrequency ablation (RFA) of colorectal cancer liver metastases (CLMs) and to describe and evaluate a modified clinical risk score (CRS) adapted for ablation as a patient stratification and prognostic tool. MATERIALS AND METHODS: This study consisted of a HIPAA-compliant institutional review board-approved retrospective review of data in 162 patients with 233 CLMs treated with percutaneous RFA between December 2002 and December 2012. Contrast material-enhanced CT was used to assess technique effectiveness 4-8 weeks after RFA. Patients were followed up with contrast-enhanced CT every 2-4 months. Overall survival (OS) and local tumor progression-free survival (LTPFS) were calculated from the time of RFA by using the Kaplan-Meier method. Log-rank tests and Cox regression models were used for univariate and multivariate analysis to identify predictors of outcomes. RESULTS: Technique effectiveness was 94% (218 of 233). Median LTPFS was 26 months. At univariate analysis, predictors of shorter LTPFS were tumor size greater than 3 cm (P < .001), ablation margin size of 5 mm or less (P < .001), high modified CRS (P = .009), male sex (P = .03), and no history of prior hepatectomy (P = .04) or hepatic arterial infusion chemotherapy (P = .01). At multivariate analysis, only tumor size greater than 3 cm (P = .01) and margin size of 5 mm or less (P < .001) were independent predictors of shorter LTPFS. Median and 5-year OS were 36 months and 31%. At univariate analysis, predictors of shorter OS were tumor size larger than 3 cm (P = .005), carcinoembryonic antigen level greater than 30 ng/mL (P = .003), high modified CRS (P = .02), and extrahepatic disease (EHD) (P < .001). At multivariate analysis, tumor size greater than 3 cm (P = .006) and more than one site of EHD (P < .001) were independent predictors of shorter OS. CONCLUSION: Tumor size of less than 3 cm and ablation margins greater than 5 mm are essential for satisfactory local tumor control. Tumor size of more than 3 cm and the presence of more than one site of EHD are associated with shorter OS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
Fong, Y., Fortner, J., Sun, R. L., Brennan, M. F., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199909000-00004 · Cited by 3,715
Abdalla, E. K., Vauthey, J.-N., Ellis, L. M., Ellis, V., Pollock, R., Broglio, K. R., Hess, K., & Curley, S. A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000128305.90650.71 · Cited by 1,750
Nordlinger, B., Guiguet, M., Vaillant, J.-C., Balladur, P., Boudjema, K., Bachellier, P., Jaeck, D., & Association Française de Chirurgie (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1254::aid-cncr5>3.0.co;2-i · Cited by 1,722
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
Ahmed, M., Solbiati, L., Brace, C. L., Breen, D. J., Callstrom, M. R., Charboneau, J. W., Chen, M.-H., Choi, B. I., de Baère, T., Dodd, G. D., et al. (2014) · Radiology · doi:10.1148/radiol.14132958 · Cited by 1,346
Self-citationLivraghi, T., Solbiati, L., Meloni, M. F., Gazelle, G. S., Halpern, E. F., & Goldberg, S. N. (2003) · Radiology · doi:10.1148/radiol.2262012198 · Cited by 1,298
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria
Goldberg, S. N., Grassi, C. J., Cardella, J. F., Charboneau, J. W., Dodd, G. D., Dupuy, D. E., Gervais, D., Gillams, A. R., Kane, R. A., Lee, F. T., et al. (2005) · Radiology · doi:10.1148/radiol.2353042205 · Cited by 1,193
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
Tomlinson, J. S., Jarnagin, W. R., DeMatteo, R. P., Fong, Y., Kornprat, P., Gonen, M., Kemeny, N., Brennan, M. F., Blumgart, L. H., & D'Angelica, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0833 · Cited by 1,187
Self-citationImage-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria
Goldberg, S. N., Grassi, C. J., Cardella, J. F., Charboneau, J. W., Dodd, G. D., Dupuy, D. E., Gervais, D. A., Gillams, A. R., Kane, R. A., Lee, F. T., et al. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.04.011 · Cited by 519
Wong, S. L., Mangu, P. B., Choti, M. A., Crocenzi, T. S., Dodd, G. D., Dorfman, G. S., Eng, C., Fong, Y., Giusti, A. F., Lu, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4450 · Cited by 433
Solbiati, L., Ahmed, M., Cova, L., Ierace, T., Brioschi, M., & Goldberg, S. N. (2012) · Radiology · doi:10.1148/radiol.12111851 · Cited by 366
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria
Goldberg, S. N., Grassi, C. J., Cardella, J. F., Charboneau, J. W., Dodd, G. D., Dupuy, D. E., Gervais, D. A., Gillams, A. R., Kane, R. A., Lee, F. T., et al. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000170858.46668.65 · Cited by 339
Livraghi, T., Solbiati, L., Meloni, F., Ierace, T., Goldberg, S. N., & Gazelle, G. S. (2003) · Cancer · doi:10.1002/cncr.11426 · Cited by 329
Gillams, A. R., & Lees, W. R. (2009) · European Radiology · doi:10.1007/s00330-008-1258-5 · Cited by 254
Treatment of liver metastases, an update on the possibilities and results
Ruers, T., & Bleichrodt, R. P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00059-x · Cited by 246
Ito, H., Are, C., Gonen, M., D'Angelica, M., DeMatteo, R. P., Kemeny, N. E., Fong, Y., Blumgart, L. H., & Jarnagin, W. R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31816c405f · Cited by 219
Self-citationQuality Improvement Guidelines for Percutaneous Transhepatic Cholangiography and Biliary Drainage
Burke, D. R., Lewis, C. A., Cardella, J. F., Citron, S. J., Drooz, A. T., Haskal, Z. J., Husted, J. W., McCowan, T. C., Van Moore, A., Oglevie, S. B., et al. (1997) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(97)70630-4 · Cited by 209
Elias, D. M., de Baère, T., Smayra, T., Ouellet, J. F., Roche, A., & Lasser, P. (2002) · British journal of surgery · doi:10.1046/j.1365-2168.2002.02081.x · Cited by 180
Pulitanò, C., Bodingbauer, M., Aldrighetti, L. A., Jong, M. C. D., Castillo, F., Schulick, R. D., Parks, R. W., Choti, M. A., Wigmore, S. J., Gruenberger, T., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1459-4 · Cited by 167
Metastatic Colon Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines
Benson, A. B., Bekaii-Saab, T., Chan, E., Chen, Y.-J., Choti, M. A., Cooper, H. S., Engstrom, P. F., Enzinger, P. C., Fakih, M. G., Fenton, M. J., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0022 · Cited by 161
Self-citationSofocleous, C. T., Petre, E. N., Gönen, M., Brown, K. T., Solomon, S. B., Covey, A. M., Alago, W., Brody, L. A., Thornton, R. H., D'Angelica, M. I., et al. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2011.01.451 · Cited by 123
Self-citationTreatment of Pulmonary Colorectal Metastases by Radiofrequency Ablation
Petre, E. N., Jia, X., Thornton, R. H., Sofocleous, C. T., Alago, W., Kemeny, N. E., & Solomon, S. B. (2012) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2012.07.003 · Cited by 89
Self-citationSofocleous, C. T., do Nascimento, R. G., Petrovic, L. M., Klimstra, D. S., Gönen, M., Brown, K. T., Brody, L. A., Covey, A. M., Thornton, R. H., Fong, Y., et al. (2008) · Radiology · doi:10.1148/radiol.2491071752 · Cited by 65
Self-citationRadiofrequency ablation of colorectal hepatic metastases
Guenette, J. P., & Dupuy, D. E. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21658 · Cited by 32
Cited by
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., Seligmann, J., De Baere, T., Osterlund, P., Yoshino, T., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.003 · Cited by 1,796
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Ruers, T., Van Coevorden, F., Punt, C. J. A., Pierie, J.-P. E. N., Borel-Rinkes, I., Ledermann, J. A., Poston, G., Bechstein, W., Lentz, M.-A., Mauer, M., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx015 · Cited by 682
Geboers, B., Scheffer, H. J., Graybill, P. M., Ruarus, A. H., Nieuwenhuizen, S., Puijk, R. S., van den Tol, P. M., Davalos, R. V., Rubinsky, B., de Gruijl, T. D., et al. (2020) · Radiology · doi:10.1148/radiol.2020192190 · Cited by 385
Shady, W., Petre, E. N., Do, K. G., Gonen, M., Yarmohammadi, H., Brown, K. T., Kemeny, N. E., D'Angelica, M., Kingham, P. T., Solomon, S. B., et al. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.08.021 · Cited by 286
Self-citation
Metadata
- Authors
- Shady, W., Petre, E. N., Gonen, M., Erinjeri, J. P., Brown, K. T., Covey, A. M., Alago, W., Durack, J. C., Maybody, M., Brody, L. A., Siegelbaum, R. H., D’Angelica, M. I., Jarnagin, W. R., Solomon, S. B., Kemeny, N. E., & Sofocleous, C. T.
- Venue
- Radiology
- Published
- 2016-02
- Volume
- 278
- Issue
- 2
- Pages
- 601-611
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W1949143911
- Cited by
- 373
- References
- 25
- FWCI
- 13.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.